84 related articles for article (PubMed ID: 21513824)
1. An analysis of the phosphoproteome of immune cell lines exposed to the immunomodulatory mycotoxin deoxynivalenol.
Nogueira da Costa A; Keen JN; Wild CP; Findlay JB
Biochim Biophys Acta; 2011 Jul; 1814(7):850-7. PubMed ID: 21513824
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of the effects of the immunomodulatory mycotoxin deoxynivalenol.
Nogueira da Costa A; Mijal RS; Keen JN; Findlay JB; Wild CP
Proteomics; 2011 May; 11(10):1903-14. PubMed ID: 21462343
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis of the human T lymphocyte cell line Jurkat and human peripheral blood mononuclear cells exposed to deoxynivalenol (DON): New mechanistic insights.
Katika MR; Hendriksen PJ; Shao J; van Loveren H; Peijnenburg A
Toxicol Appl Pharmacol; 2012 Oct; 264(1):51-64. PubMed ID: 22846391
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the modes of action of deoxynivalenol (DON) in the human Jurkat T-cell line.
Katika MR; Hendriksen PJ; van Loveren H; A C M Peijnenburg A
J Immunotoxicol; 2015; 12(3):206-16. PubMed ID: 24988111
[TBL] [Abstract][Full Text] [Related]
5. Phosphoproteome Analysis Reveals the Molecular Mechanisms Underlying Deoxynivalenol-Induced Intestinal Toxicity in IPEC-J2 Cells.
Zhang ZQ; Wang SB; Wang RG; Zhang W; Wang PL; Su XO
Toxins (Basel); 2016 Sep; 8(10):. PubMed ID: 27669298
[TBL] [Abstract][Full Text] [Related]
6. Proteome of H-411E (liver) cells exposed to insulin and tumor necrosis factor-alpha: analysis of proteins involved in insulin resistance.
Solomon SS; Buss N; Shull J; Monnier S; Majumdar G; Wu J; Gerling IC
J Lab Clin Med; 2005 May; 145(5):275-83. PubMed ID: 15902099
[TBL] [Abstract][Full Text] [Related]
7. Dynamic changes in ribosome-associated proteome and phosphoproteome during deoxynivalenol-induced translation inhibition and ribotoxic stress.
Pan X; Whitten DA; Wilkerson CG; Pestka JJ
Toxicol Sci; 2014 Mar; 138(1):217-33. PubMed ID: 24284785
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology.
Yan G; Li L; Tao Y; Liu S; Liu Y; Luo W; Wu Y; Tang M; Dong Z; Cao Y
Proteomics; 2006 Mar; 6(6):1810-21. PubMed ID: 16470631
[TBL] [Abstract][Full Text] [Related]
9. Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining.
Stasyk T; Morandell S; Bakry R; Feuerstein I; Huck CW; Stecher G; Bonn GK; Huber LA
Electrophoresis; 2005 Jul; 26(14):2850-4. PubMed ID: 15966015
[TBL] [Abstract][Full Text] [Related]
10. Early phosphoproteomic changes in the mouse spleen during deoxynivalenol-induced ribotoxic stress.
Pan X; Whitten DA; Wu M; Chan C; Wilkerson CG; Pestka JJ
Toxicol Sci; 2013 Sep; 135(1):129-43. PubMed ID: 23811945
[TBL] [Abstract][Full Text] [Related]
11. The Fusarium toxin deoxynivalenol disrupts phenotype and function of monocyte-derived dendritic cells in vivo and in vitro.
Bimczok D; Döll S; Rau H; Goyarts T; Wundrack N; Naumann M; Dänicke S; Rothkötter HJ
Immunobiology; 2007; 212(8):655-66. PubMed ID: 17869643
[TBL] [Abstract][Full Text] [Related]
12. Differential immune modulation by deoxynivalenol (vomitoxin) in mice.
Islam MR; Roh YS; Kim J; Lim CW; Kim B
Toxicol Lett; 2013 Aug; 221(2):152-63. PubMed ID: 23791694
[TBL] [Abstract][Full Text] [Related]
13. Phosphoproteome profile of human liver Chang's cell based on 2-DE with fluorescence staining and MALDI-TOF/TOF-MS.
Liu J; Cai Y; Wang J; Zhou Q; Yang B; Lu Z; Jiao L; Zhang D; Sui S; Jiang Y; Ying W; Qian X
Electrophoresis; 2007 Dec; 28(23):4348-58. PubMed ID: 17987627
[TBL] [Abstract][Full Text] [Related]
14. Ingestion of low doses of deoxynivalenol does not affect hematological, biochemical, or immune responses of piglets.
Accensi F; Pinton P; Callu P; Abella-Bourges N; Guelfi JF; Grosjean F; Oswald IP
J Anim Sci; 2006 Jul; 84(7):1935-42. PubMed ID: 16775078
[TBL] [Abstract][Full Text] [Related]
15. Mycotoxin deoxynivalenol (DON) mediates biphasic cellular response in intestinal porcine epithelial cell lines IPEC-1 and IPEC-J2.
Diesing AK; Nossol C; Panther P; Walk N; Post A; Kluess J; Kreutzmann P; Dänicke S; Rothkötter HJ; Kahlert S
Toxicol Lett; 2011 Jan; 200(1-2):8-18. PubMed ID: 20937367
[TBL] [Abstract][Full Text] [Related]
16. New insights into mycotoxin mixtures: the toxicity of low doses of Type B trichothecenes on intestinal epithelial cells is synergistic.
Alassane-Kpembi I; Kolf-Clauw M; Gauthier T; Abrami R; Abiola FA; Oswald IP; Puel O
Toxicol Appl Pharmacol; 2013 Oct; 272(1):191-8. PubMed ID: 23735874
[TBL] [Abstract][Full Text] [Related]
17. Two-dimensional gel electrophoresis approach for CTL phosphoproteome analysis.
Rocchetti MT; Papale M; Gesualdo L
Methods Mol Biol; 2014; 1186():243-51. PubMed ID: 25149311
[TBL] [Abstract][Full Text] [Related]
18. Mycotoxins nivalenol and deoxynivalenol differentially modulate cytokine mRNA expression in Jurkat T cells.
Severino L; Luongo D; Bergamo P; Lucisano A; Rossi M
Cytokine; 2006 Oct; 36(1-2):75-82. PubMed ID: 17166736
[TBL] [Abstract][Full Text] [Related]
19. The effects of deoxynivalenol on gene expression in the murine thymus.
van Kol SW; Hendriksen PJ; van Loveren H; Peijnenburg A
Toxicol Appl Pharmacol; 2011 Feb; 250(3):299-311. PubMed ID: 21074547
[TBL] [Abstract][Full Text] [Related]
20. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
